InvestorsObserver
Sign Up Login

MEDS TRxADE HEALTH Inc.

$6.45 $-0.05 (-0.77%)
15 Minute Delayed Price Enable Real-Time Price
Add to Watchlist Compare
Overall

MEDS Stock Analysis Overview

What this means: InvestorsObserver gives TRxADE HEALTH Inc. (MEDS) an overall rank of 26, which is below average. TRxADE HEALTH Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 26 means that 74% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

MEDS Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

MEDS Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

MEDS Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

MEDS Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

MEDS Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

MEDS Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

MEDS Stock Analysis Overview

What this means: InvestorsObserver gives TRxADE HEALTH Inc. (MEDS) an overall rank of 26, which is below average. TRxADE HEALTH Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 26 means that 74% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full MEDS report

MEDS Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

MEDS Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

MEDS Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

MEDS Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

MEDS Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

MEDS Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

TRxADE HEALTH Inc. (MEDS) Analyst Forecast

MEDS Price, Volume, Earnings, and Dividend Date

  • Last Price $6.45
  • Previous Close $6.50
  • Change $-0.05
  • Open $6.63
  • Volume 16,467
  • Avg. Volume (100-day) 277,012
  • Market Cap 9,070,945
  • Days Range 6.28 - 6.825
  • 52-week Range 3.69 - 44.56
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 05/20/24
  • Sector —
  • Industry —
  • Avg. Analyst Rec. Premium
  • Beta 0.566
  • PEG Ratio —

TRxADE HEALTH Inc. (MEDS) Company Description

Trxade Group Inc engages in designing and developing business to business web-based platform which provides buying and selling opportunities for pharmacies and national suppliers of the pharmaceutical industry. The products developed by the company are trxade.com which is a web-based pharmaceutical platform for promoting and trade among independent pharmacies and suppliers, inventoryrx.com which is also a platform for promoting and trading among suppliers and manufacturers nationally, pharmabayonline which provides access to pharmaceutical data analytics to United States based independent pharmacies, and rxguru which is a service based desktop software applications for providing drug pricing and analytics.

TRxADE HEALTH Inc. (MEDS) Stock Chart

View Interactive MEDS chart

My Watchlists

Top Stocks